Search results
Results from the WOW.Com Content Network
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group , its core services range from late discovery to large-scale commercial manufacturing.
Samsung Biologics is a biopharmaceutical division of Samsung, founded in 2011. It has contract development and manufacturing (CDMO) services including drug substance and product manufacturing and bioanalytical testing services. The company is headquartered in Incheon, South Korea and its existing three plants comprises the largest biologic ...
For premium support please call: 800-290-4726 more ways to reach us
Phone support is available for account management and password reset help, Mon-Fri: 8am-12am ET; Sat: 8am-10pm ET. For additional hours of operation for different services visit our support options page for contact info.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Samsung SDS was established in 1985 as Samsung Data Systems as a subsidiary of Samsung Group, and was renamed Samsung SDS in 1997. The company was founded to provide ICT services to Samsung Group affiliates based on contemporary digital technologies, including mobile, social media, sensors, cloud technology, and others.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Samsung is a major supplier for Apple – first providing memory for the early iPod devices in 2005, [34] and Apple is a key customer for Samsung – in 2012 its component sales were thought to be worth in the region of $8 billion revenue to Samsung [193] – to the point where Apple CEO Tim Cook originally opposed litigation against Samsung ...